LUMIRADX LTD - *W EXP 09/28/202 (LMDWF)

CUSIP: G5709L117

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / *W EXP 09/28/202
Total 13F shares
5,583,256
Share change
-709,713
Total reported value
$42,896
Price per share
$0.01
Number of holders
3
Value change
-$5,708
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP G5709L117?
CUSIP G5709L117 identifies LMDWF - LUMIRADX LTD - *W EXP 09/28/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) as of Q1 2024

As of 31 Mar 2024, LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,583,256 shares. The largest 3 holders included CVS HEALTH Corp, GOLDMAN SACHS GROUP INC, and Ancora Advisors LLC. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.